Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Myeloid Cells in Circulation and Tumor Microenvironment of Colorectal Cancer Patients with Early and Advanced Disease Stages
Salman M. Toor et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
Paola De Cicco et al.
FRONTIERS IN IMMUNOLOGY (2020)
Myeloid-derived suppressor cells in the patients with liver resection for hepatitis B virus-related hepatocellular carcinoma
Wei-Chen Lee et al.
SCIENTIFIC REPORTS (2019)
Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer
Peiwen Ma et al.
FRONTIERS IN IMMUNOLOGY (2019)
Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer
Elham Safarzadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Myeloid-Derived Suppressor Cells in Sepsis
Irene T. Schrijver et al.
FRONTIERS IN IMMUNOLOGY (2019)
Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer
Yoshikane Yamauchi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Blockade of Myeloid-Derived Suppressor Cell Expansion with All-Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy
Raimund Bauer et al.
CANCER RESEARCH (2018)
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer
Masoud F. Tavazoie et al.
CELL (2018)
Myeloid derived-suppressor cells: their role in cancer and obesity
Suzanne Strand-Rosenberg
CURRENT OPINION IN IMMUNOLOGY (2018)
Plasticity of myeloid-derived suppressor cells in cancer
Evgenii Tcyganov et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
The role of hypoxia in shaping the recruitment of proangiogenic and immunosuppressive cells in the tumor microenvironment
Salem Chouaib et al.
Wspolczesna Onkologia-Contemporary Oncology (2018)
CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients
Tatiana A. Karakasheva et al.
JCI INSIGHT (2018)
On the origin of myeloid-derived suppressor cells
Camilla Rydberg Millrud et al.
ONCOTARGET (2017)
Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression
Huifang Shi et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
A subpopulation that may correspond to granulocytic myeloid-derived suppressor cells reflects the clinical stage and progression of cutaneous melanoma
Ivan Stanojevic et al.
INTERNATIONAL IMMUNOLOGY (2016)
Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment Regimen
Emeric Limagne et al.
CANCER RESEARCH (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients
Thomas Condamine et al.
SCIENCE IMMUNOLOGY (2016)
High Frequency of Mononuclear Myeloid-Derived Suppressor Cells is Associated with Exacerbation of Inflammatory Bowel Disease
Qinhua Xi et al.
IMMUNOLOGICAL INVESTIGATIONS (2015)
Transcriptional regulation of myeloid-derived suppressor cells
Thomas Condamine et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer
Li-Ying OuYang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
Fokhrul Hossain et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Pre- and post-operative evaluation: percentages of circulating myeloid-derived suppressor cells in rectal cancer patients
L. Yuan et al.
NEOPLASMA (2015)
Increased Levels of Granulocytic Myeloid-Derived Suppressor Cells in Peripheral Blood and Tumour Tissue of Pancreatic Cancer Patients
Yazan S. Khaled et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Clinical Significance and Functional Studies of Myeloid-Derived Suppressor Cells in Chronic Hepatitis C Patients
Weiping Cai et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal Carcinoma
Bin Zhang et al.
PLOS ONE (2013)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
Mitsugu Fujita et al.
CANCER RESEARCH (2011)
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
Julie Vincent et al.
CANCER RESEARCH (2010)
Use of α,25-Dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma
Jarrett E. Walsh et al.
HUMAN IMMUNOLOGY (2010)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
Tumor-induced immune dysfunctions caused by myeloid suppressor cells
V Bronte et al.
JOURNAL OF IMMUNOTHERAPY (2001)